EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions
Por:
Ständer, S, Pereira, MP, Zeidler, C, Legat, FJ, Misery, L, Loenndahl, L, Bewley, AP, Brenaut, E, Bobko, S, Elberling, J, Evers, AWM, Garcovich, S, Gieler, U, Goncalo, M, Kupfer, J, Lambert, J, Lvov, A, Metz, M, Michenko, A, Papadavid, E, Reich, A, Savk, E, Schneider, G, Schut, C, Serra-Baldrich, E, Ständer, HF, Szepietowski, JC, Wallengren, J, Weisshaar, E, Augustin, M
Publicada:
1 sep 2024
Ahead of Print:
1 may 2024
Resumen:
Chronic pruritus (CP) is frequent in general medicine and the most common complaint in general dermatology. The prevalence of CP is expected to rise in the future due to the ageing population. The clinical presentation, underlying aetiology and treatment strategy of CP are heterogeneous. Also, individual treatment aims and physical, psychic and economic burdens of patients might vary. Chronic prurigo (CPG) is the most severe disease in the chronic pruritus spectrum, being associated with long-standing scratch-induced skin lesions and a therapy refractory itch-scratch-cycle. It is thus important to raise disease awareness for CP and CPG in the general public and among decision-makers in the health system. Further, there is a need to support a rational clinical framework to optimize both diagnostics and therapeutics. Currently, there is still a shortcoming regarding approved therapies and understanding CP/CPG as severe medical conditions. Therefore, the EADV Task Force Pruritus decided to publish this white paper based on several consensus meetings. The group consented on the following goals: (a) ensure that CP is recognized as a serious condition, (b) increase public awareness and understanding of CP and CPG as chronic and burdensome diseases that can greatly affect a person's quality of life, (c) clarify that in most cases CP and CPG are non-communicable and not caused by a psychiatric disease, (d) improve the support and treatment given to patients with CP to help them manage their disease and (e) publicize existing therapies including current guidelines. We aim to point to necessary improvements in access and quality of care directed to decision-makers in health policy, among payers and administrations as well as in practical care.
Filiaciones:
Ständer, S:
Univ Hosp Munster, Sect Pruritus Med, Dept Dermatol & Ctr Chron Pruritus, Von Esmarch Str 58, D-48149 Munster, Germany
Pereira, MP:
Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
Free Univ Berlin, Berlin, Germany
Humboldt Univ, Berlin, Germany
Fraunhofer Inst Translat Med & Pharmacol ITMP, Immunol & Allergol, Berlin, Germany
Zeidler, C:
Univ Hosp Munster, Sect Pruritus Med, Dept Dermatol & Ctr Chron Pruritus, Von Esmarch Str 58, D-48149 Munster, Germany
Legat, FJ:
Med Univ Graz, Dept Dermatol & Venereol, Graz, Austria
Misery, L:
Univ Hosp Brest, Dept Dermatol, Brest, France
Loenndahl, L:
Karolinska Inst, Dept Med Solna, Dermatol & Venereol Unit, Stockholm, Sweden
Bewley, AP:
Queen Mary Univ London, Barts Hlth NHS Trust, London, England
Brenaut, E:
Univ Hosp Brest, Dept Dermatol, Brest, France
Bobko, S:
Moscow Sci & Pract Ctr Dermatovenerol & Cosmetol, Moscow, Russia
Elberling, J:
Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
Evers, AWM:
Leiden Univ, Inst Psychol, Hlth Med & Neuropsychol Unit, Leiden, Netherlands
Garcovich, S:
Dermatol Outpatient Off, Rome, Italy
Gieler, U:
Vitos Klinikum Giessen, Dept Psychosomat, Giessen, Germany
Goncalo, M:
Univ Coimbra, Univ Hosp, Fac Med, Dept Dermatol, Coimbra, Portugal
Kupfer, J:
Justus Liebig Univ Giessen, Inst Med Psychol, Giessen, Germany
Lambert, J:
Univ Antwerp, Antwerp Univ Hosp, Dept Dermatol, Antwerp, Belgium
Lvov, A:
Cent State Med Acad, Dept Dermatovenereol & Cosmetol, Dept Presidential Affairs, Moscow, Russia
Lomonosov Moscow State Univ, Med Res & Educ Ctr, Moscow, Russia
Metz, M:
Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
Free Univ Berlin, Berlin, Germany
Humboldt Univ, Berlin, Germany
Fraunhofer Inst Translat Med & Pharmacol ITMP, Immunol & Allergol, Berlin, Germany
Michenko, A:
Cent State Med Acad, Dept Dermatovenereol & Cosmetol, Dept Presidential Affairs, Moscow, Russia
Lomonosov Moscow State Univ, Med Res & Educ Ctr, Moscow, Russia
Papadavid, E:
Natl & Kapodistrian Univ Athens, Attikon Gen Hosp, Dept Dermatol & Venereol 2, Athens, Greece
Reich, A:
Univ Rzeszow, Dept Dermatol, Rzeszow, Poland
Savk, E:
Aydin Adnan Menderes Univ, Dept Dermatol, Aydin, Turkiye
Schneider, G:
Univ Hosp Munster, Dept Psychosomat Med & Psychotherapy, Munster, Germany
Schut, C:
Justus Liebig Univ Giessen, Inst Med Psychol, Giessen, Germany
Serra-Baldrich, E:
St Pau Hosp, Dept Dermatol, Barcelona, Spain
Ständer, HF:
Dermatol Practice, Bad Bentheim, Germany
Szepietowski, JC:
Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
Wallengren, J:
Lund Univ, Dept Dermatol & Venereol, Lund, Sweden
Weisshaar, E:
Heidelberg Univ, Dept Dermatol, Div Occupat Dermatol, Heidelberg, Germany
Augustin, M:
Univ Hosp Hamburg Eppendorf, Competence Ctr Healthcare Res Dermatol CVderm, Inst Healthcare Res Dermatol & Nursing IVDP, Hamburg, Germany
Green Published, hybrid
|